First National Bank Sioux Falls Takes Position in Cencora, Inc. (NYSE:COR)

First National Bank Sioux Falls acquired a new stake in Cencora, Inc. (NYSE:COR) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,000 shares of the company’s stock, valued at approximately $243,000.

Several other large investors have also made changes to their positions in the business. Fisher Asset Management LLC acquired a new position in shares of Cencora in the 4th quarter valued at $244,000. Trust Co. of Vermont acquired a new position in Cencora during the fourth quarter worth $62,000. Wahed Invest LLC acquired a new stake in shares of Cencora in the fourth quarter valued at about $567,000. Vanguard Group Inc. purchased a new position in shares of Cencora in the fourth quarter worth about $4,212,508,000. Finally, Hennessy Advisors Inc. purchased a new position in shares of Cencora in the fourth quarter worth about $3,307,000. 97.52% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Cencora

In other Cencora news, CEO Steven H. Collis sold 10,754 shares of the business’s stock in a transaction on Tuesday, April 16th. The shares were sold at an average price of $237.48, for a total value of $2,553,859.92. Following the transaction, the chief executive officer now directly owns 285,088 shares of the company’s stock, valued at approximately $67,702,698.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, COO Robert P. Mauch sold 57,564 shares of the company’s stock in a transaction on Monday, April 15th. The shares were sold at an average price of $235.09, for a total transaction of $13,532,720.76. Following the transaction, the chief operating officer now directly owns 24,412 shares of the company’s stock, valued at approximately $5,739,017.08. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Steven H. Collis sold 10,754 shares of the company’s stock in a transaction on Tuesday, April 16th. The stock was sold at an average price of $237.48, for a total transaction of $2,553,859.92. Following the transaction, the chief executive officer now directly owns 285,088 shares in the company, valued at $67,702,698.24. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,956,675 shares of company stock valued at $422,352,056. 15.80% of the stock is owned by company insiders.

Cencora Stock Down 3.9 %

Cencora stock traded down $9.32 during trading on Thursday, reaching $227.96. The stock had a trading volume of 3,534,603 shares, compared to its average volume of 1,389,967. Cencora, Inc. has a 52-week low of $171.65 and a 52-week high of $246.75. The business has a 50 day moving average price of $229.58 and a 200 day moving average price of $227.67. The company has a quick ratio of 0.53, a current ratio of 0.89 and a debt-to-equity ratio of 3.41. The stock has a market cap of $45.47 billion, a PE ratio of 24.76, a P/E/G ratio of 1.66 and a beta of 0.48.

Cencora (NYSE:COR) last announced its earnings results on Wednesday, May 1st. The company reported $3.80 EPS for the quarter, beating analysts’ consensus estimates of $3.65 by $0.15. The business had revenue of $68.41 billion for the quarter, compared to analysts’ expectations of $70.60 billion. Cencora had a net margin of 0.67% and a return on equity of 268.67%. The company’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period in the previous year, the company posted $3.50 EPS. On average, analysts predict that Cencora, Inc. will post 13.44 EPS for the current year.

Cencora Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 24th. Shareholders of record on Friday, May 10th were paid a $0.51 dividend. The ex-dividend date of this dividend was Thursday, May 9th. This represents a $2.04 annualized dividend and a yield of 0.89%. Cencora’s dividend payout ratio is currently 22.32%.

Wall Street Analyst Weigh In

COR has been the subject of several recent analyst reports. Citigroup raised their price objective on shares of Cencora from $265.00 to $280.00 and gave the stock a “buy” rating in a research report on Tuesday, April 30th. SVB Leerink reiterated an “outperform” rating and set a $275.00 price target on shares of Cencora in a research report on Thursday. StockNews.com cut shares of Cencora from a “strong-buy” rating to a “buy” rating in a report on Thursday, May 2nd. Finally, Robert W. Baird lifted their price objective on shares of Cencora from $275.00 to $277.00 and gave the company an “outperform” rating in a report on Thursday, May 2nd. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, Cencora presently has a consensus rating of “Moderate Buy” and a consensus target price of $235.30.

Cencora Company Profile

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.